-
Dystrophy type 1 (DM1), Spinal Muscular Atrophy (SMA) and Spinal and Bulbar Muscular Atrophy (SBMA). The group has also developed extracellular vesicle nanotechnologies for targeted cell delivery and
-
. Applicants must hold a PhD in Chemistry, Physics, or a related subject area, (or be close to completion) prior to taking up your appointment. The research requires experience with DNA nanotechnology
Searches related to nanotechnology
Enter an email to receive alerts for nanotechnology positions